Pedro Bermejo

Pedro Bermejo is currently the SMD and Head of Gene Therapy and Epilepsy in Translational Medicine at UCB. Pedro is also the Founder and Chief Medical Officer at Xana, Smart Neurostimulation. Pedro has a diverse background in neurology, with experience as a Medical Director at Oryzon Genomics SA, a Professor in neuroanatomy at Universidad Europea, and a Neurologist at various hospitals. Pedro holds a PhD in Medicine (Neuroscience) from Universidad Autónoma de Madrid and has completed multiple master's degrees in fields related to medicine. Pedro is known for their expertise in neurology and translational medicine.